Abstract
Screening for glaucoma, usually by measuring intraocular pressure, has been popular, but repeated analysis indicates poor sensitivity and specificity. More extensive testing is required. Such testing should be focused on high-risk groups, including blacks and the elderly. Regular comprehensive eye examinations, on a schedule adjusted for these and other risk factors, are probably the most cost-efficient means of identifying patients with glaucoma. The primary care provider has a pivotal role: to encourage patients to undergo such examinations when warranted; and to encourage those on intraocular-pressure-lowering medications to comply with their medication use.
Similar content being viewed by others
References
U.S. Preventive Services Task Force. Guide to clinical preventive services: an assessment of the effectiveness of 169 interventions. Baltimore: Williams and Wilkins, 1989.
Sommer A. Disabling ocular disorders. In: Last JM, ed. (Maxcy-Rosenau) Public health and preventive medicine. 12th ed. Norwalk, CT: Appleton-Century-Crofts, 1986;1297–311.
Power EJ, Wagner JL, Duffy BM. Screening for open-angle glaucoma in the elderly. Washington, DC: Office on Technology Assessment, Congress of the United States, 1988.
Sommer A. Epidemiology and statistics for the ophthalmologist. New York and Oxford: Oxford University Press, 1980.
Leske MC. The epidemiology of open-angle glaucoma: a review. Am J Epidemiol. 1983;118:166–91.
Preferred practice pattern: primary open angle glaucoma. San Francisco, CA: American Academy of Ophthalmology, 1989.
Sommer A. Epidemiology as it relates to screening for glaucoma (summary and discussion). Surv Ophthalmol. 1989;33(suppl):441–50.
Sommer A. Intraocular pressure and glaucoma. Am J Ophthalmol. 1989;107:186–8.
David R, Livingston DG, Luntz MH. Ocular hypertension. A long-term follow-up of treated and untreated patients. Br J Ophthalmol. 1977;61:668–74.
Hollow FC, Graham PA. Intraocular pressure, glaucoma and glaucoma suspects in a defined population. Br J Ophthalmol. 1966;50:570–86.
Sommer A, Tielsch J. Preliminary results of the Baltimore Eye Study (personal communication, 1989).
Perkins S. The Bedford glaucoma survey. I. Long-term follow-up of borderline cases. Br J Ophthalmol. 1973;57:179–85.
Sommer A, Enger C, Witt K. Screening for glaucomatous field loss with automated threshold perimetry. Am J Ophthalmol. 1987;103:681–4.
Rock WJ, Drance SM, Morgan RW. Visual field screening in glaucoma. Arch Ophthalmol. 1973;89:287–90.
Quigley HA, Addicks EM, Green R. Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defects in glaucoma, ischemic disc edema and toxic neuropathy. Arch Ophthalmol. 1982;100:135–46.
Sommer A, Quigley HA, Robin AL, Miller NR, Katz J, Arkell S. Evaluation of nerve fiber layer assessment. Arch Ophthalmol. 1984;102:1766–71.
Sommer A, Miller N, Pollack I, Maumene AE, George T. The nerve fiber layer in the diagnosis of glaucoma. Arch Ophthalmol. 1977;95:2149–56.
Katz J, Sommer A. Similarities between the visual fields of ocular hypertensive and normal eyes. Arch Ophthalmol. 1986;104:1648–51.
Preferred practice pattern: the glaucoma suspect. San Francisco, CA: American Academy of Ophthalmology, 1989.
Preferred practice pattern: the comprehensive eye examination in an otherwise asymptomatic adult. San Francisco, CA: American Academy of Ophthalmology, 1988.
Hiller R, Kahn HA. Blindness from glaucoma. Am J Ophthalmol. 1975;80:62–9.
Martin MJ, Sommer A. Race and primary open angle glaucoma. Am J Ophthalmol. 1985;99:383–7.
Javitt JC, Canner JK, Sommer A. Cost effectiveness of current approaches to the control of retinopathy in type I diabetes. Ophthalmology. 1989;96:255–64.
Javitt JC, Canner JK, Frank RG, Steinwachs DM, Sommer A. Detecting and healing retinopathy in type-I diabetics: a health policy model. Opthalmology. 1990 (in press).
Katz J, Sommer A. Risk factors for primary open-angle glaucoma. Am J Prev Med. 1988;4:110–4.
Perkins ES, Phelps CD. Open angle glaucoma, ocular hypertension, low tension glaucoma and refraction. Arch Ophthalmol. 1982;100:1464–7.
Drance SM, Schulzer M, Douglas GR, Sweeney VP. Use of discriminant analysis. II. Identification of persons with glaucomatous visual field defects. Arch Ophthalmol. 1978;96:1571–3.
Strahlman E, Ford D, Whelton P, Sommer A. Vision screening in a primary care setting: a missed opportunity. Arch Intern Med. 1990 (in press).
Kass MA, Gordon M, Morley RE, Jr, Meltzer DW, Goldberg JJ. Compliance with topical timolol treatment. Am J Ophthalmol. 1987;103:188–93.
Author information
Authors and Affiliations
Additional information
Received from the Dana Center for Preventive Ophathalmology, the Wilmer Eye Institute, and the School of Hygiene and Public Health, The Johns Hopkins University, Baltimore, Maryland.
Supported by research grants #EY03605 and #ET05091 from the National Institutes of Health, and by the Johns Hopkins Health of the Public Program.
Rights and permissions
About this article
Cite this article
Sommer, A. Glaucoma screening. J Gen Intern Med 5 (Suppl 2), S33–S37 (1990). https://doi.org/10.1007/BF02600838
Issue Date:
DOI: https://doi.org/10.1007/BF02600838